川崎病的诊断和治疗方法
1Division of Pediatric Cardiology, College of Physicians and Surgeons, Columbia University, New York, NY.
JAMA
|May 22, 1991
概括
川崎病是一种影响儿童的急性血管炎. 早期使用阿司匹林和静脉注射马球蛋白治疗对于预防冠状动脉动脉瘤和长期心脏并发症至关重要.
科学领域:
- 儿科 儿科 儿科
- 类风湿病学 类风湿病学
- 心脏病学 心脏病学
背景情况:
- 川崎病是一种急性血管炎,其特征症状包括发烧,皮疹和炎症.
- 心脏干扰,如心肌炎和冠状动脉动脉瘤,是一个重大问题.
- 病因仍然未知,怀疑是一种传染病原体.
研究的目的:
- 总结川崎病的临床表现,心脏影响和治疗方法.
- 突出长期风险,特别是冠状动脉异常.
- 强调需要进行仔细的随访,并将川崎病视为潜在的冠状动脉疾病风险因素.
主要方法:
- 考察川崎病的临床特征和已知的结果.
- 分析早期和晚期的心脏表现.
- 评估当前的治疗策略和长期预后.
主要成果:
- 早期的心脏影响包括心肌炎和心周炎症;冠状动脉动脉瘤是一个长期风险.
- 静脉注射的马球蛋白和阿司匹林是预防动脉瘤的标准治疗方法.
- 巨型动脉瘤增加了阻塞性冠状动脉疾病的风险,可能需要绕道移植.
结论:
- 川崎病需要迅速管理,以减轻心脏风险.
- 长期跟踪是必不可少的,特别是对于冠状动脉异常的患者.
- 儿童川崎病可能是未来冠状动脉疾病的危险因素,特别是在西方人群中.
相关概念视频
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis IV: Nursing Management
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...


